At a glance
- Originator Kaken Pharmaceutical
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 27 Nov 2000 No-Development-Reported for Bacterial infections in Japan (Parenteral)